• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Optimised Ten-Minute Urine Test Speeds High-Throughput Clinical Metabolomics Screening

by
November 13, 2026
in Biology
Reading Time: 5 mins read
0
Optimised Ten-Minute Urine Test Speeds High-Throughput Clinical Metabolomics Screening

Optimised Ten-Minute Urine Test Speeds High-Throughput Clinical Metabolomics Screening

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Analytical scientists have established a streamlined dilute-and-shoot ultra-high-performance liquid chromatography-mass spectrometry method that shortens urine metabolomic profiling runs to ten minutes while preserving broad chemical coverage across clinical cohorts. Untargeted urinary metabolomics using liquid chromatography coupled with mass spectrometry offers substantial utility for clinical biomarker discovery and mechanistic investigations, yet extensive cohort profiling has historically been constrained by lengthier chromatographic separation gradients and inconsistent sample preparation workflows. To address the operational bottlenecks inherent to profiling hundreds or thousands of human samples, researchers systematically refined eight interrelated extraction, chromatographic, and mass spectrometry parameters to construct an expedited, robust analytical protocol suitable for high-throughput screening initiatives.

Urine represents an advantageous biological matrix for large-scale clinical investigations because it can be collected easily and non-invasively without imposing physical burdens on participants. The substantial volumes typically voided allow investigators to conduct multiple analytical assays on identical specimens, thereby facilitating replication, cross-platform technical validation, and longitudinal tracking of therapeutic interventions or natural disease progression. The matrix contains a chemically diverse repertoire of biological compounds and downstream metabolic products that mirror dynamic physiological states. While urinary molecules such as albumin, prostate cancer antigen 3, and 2-hydroxyglutarate serve established diagnostic roles across nephrology, oncology, and metabolic medicine, comprehensive untargeted profiling requires robust analytical platforms capable of capturing diverse molecular classes while minimizing sample degradation during protracted testing sequences.

To bypass the labor-intensive sample clean-up procedures and analyte losses frequently observed during solid-phase extraction, the investigative team deployed a dilute-and-shoot methodology. This strategy dilutes raw urine with a dedicated solvent prior to immediate, direct injection into the chromatography system, minimizing sample handling steps, technician intervention time, and operational costs. The researchers methodically evaluated eight core experimental parameters across the entire analytical pipeline, encompassing the metabolite extraction solvent, sample dilution factor, chromatographic gradient duration, mobile phase flow rate, sample injection volume, gradient curve profile, full-scan automatic gain control, and tandem mass spectrometry automatic gain control settings. In total, sixty discrete parameter comparisons were analyzed in triplicate through Compound Discoverer software, generating 180 comparative evaluations to guide protocol selection.

Method performance across parameter iterations was quantitatively benchmarked by evaluating the overall number of putatively annotated metabolites, individual peak shape ratings, and the chromatographic performance of endogenous creatinine. Creatinine serves as a ubiquitous, stable endogenous reference compound in human urine, making its analytical behavior an effective gauge of chromatographic integrity. Peak quality factors, including the zig-zag quality index, full width at half maximum to base width ratio, peak jaggedness, and modality indices, were quantitatively tracked to detect peak distortion, split shapes, or poor resolution, with lower numerical values corresponding to superior chromatographic peak geometry.

During extraction solvent evaluation, the investigators evaluated ten candidate solvents and solvent combinations against urine samples. Visual examination of chromatograms indicated that neat water was the sole solvent providing baseline chromatographic resolution of early-eluting peaks between 0.5 and 2.5 minutes. Water extraction yielded the highest count of detected metabolites at 114 features, demonstrating a statistically significant increase compared to five alternative solvent systems alongside significantly higher average peak quality ratings over three competing formulations. Notably, creatinine went completely undetected when pure methanol or isopropanol-water mixtures were employed, precluding quality factor scoring for those solvent groups. Pure water demonstrated minimal or zero creatinine peak quality factor values across metrics, with the sole exception of peak jaggedness, leading to the selection of 100 percent water as the optimal extraction medium.

Subsequent optimization of the water dilution ratio sought to balance the detection of low-abundance metabolites against the physical risks of detector saturation and column overload. A 1:1 urine-to-water dilution yielded a significantly higher number of detected metabolites than higher dilutions of 1:5 or 1:10, without showing significant differences in average peak rating across detected compounds. Although creatinine peak area was greatest under 1:1 dilution conditions, creatinine chromatographic peak rating favored higher dilutions, and the 1:1 mixture exhibited non-zero values for peak jaggedness and modality. The researchers retained the 1:1 dilution factor to maximize coverage of minor metabolites, while acknowledging that post-column infusion matrix-factor profiling remained beyond the untargeted scope of the study, relying instead on internal standard reproducibility across pooled quality control samples to demonstrate matrix stability.

Chromatographic parameters were optimized on a reversed-phase Vanquish Accucore C18 analytical column operating with mobile phases of water and acetonitrile, each supplemented with 0.1 percent formic acid by volume. The team successfully compressed the active data acquisition window to 6.5 minutes across a 70 to 1000 mass-to-charge ratio scan range, followed by a 3.5-minute column washing and re-equilibration step, yielding a complete run cycle of 10 minutes. Comparative testing demonstrated no significant discrepancy in metabolite numbers or overall peak ratings between this 10-minute method and an earlier 15-minute sequence, while the shortened run generated a modality value of zero for creatinine, verifying refined peak symmetry. Tests across injection volumes ranging from 0.5 to 5 microliters demonstrated that while a 5-microliter volume detected slightly more features, it caused observable peak broadening and lower creatinine peak ratings; consequently, a 2-microliter injection volume was selected to avert column saturation. Evaluating mobile phase flow rates identified 0.4 milliliters per minute as optimal, delivering significantly greater metabolite detection than competing rates, and gradient curve factor 7 was chosen to optimize separation efficiency.

Mass spectrometer tuning on an Orbitrap Exploris 240 instrument in positive electrospray ionization mode balanced spectral acquisition speed against ion accumulation transients. Setting the full-scan automatic gain control target to 150 percent with a 100-millisecond maximum ion injection time delivered stable signal intensity and peak quality without needlessly extending cycle duration. For data-dependent tandem mass spectrometry acquisition, raising the target above 100 percent increased signal intensity marginally without expanding the number of annotated chemical features, pointing to potential ion saturation effects. Consequently, a tandem automatic gain control target of 100 percent paired with a 50-millisecond maximum injection time was implemented to preserve acquisition frequency while maintaining zero values across zig-zag, jaggedness, and modality peak metrics.

The fully integrated 10-minute dilute-and-shoot method was validated through application to a clinical inflammatory bowel disease research cohort comprising 1094 human urine samples collected across three clinical studies: the ENIP study exploring enteral nutrition in healthy individuals, the CD-TREAT diet study examining food-based diets designed to replicate exclusive enteral nutrition, and the randomized iPENS trial evaluating food reintroduction in pediatric and young adult Crohn’s disease patients. Across 1344 total instrument injections, including 250 pooled quality control runs, the method annotated over 1500 metabolites at Metabolomics Standards Initiative level 2 within 182.3 hours of operational runtime. Compared to the previous 15-minute analytical protocol which would have required 273.5 hours, the optimized platform saved over 91 hours of instrument time without sacrificing spectral feature coverage.

The research team also investigated post-acquisition data processing strategies, comparing non-normalized data against creatinine normalisation and probabilistic quotient normalisation across the clinical cohort. Evaluating precision using a threshold of metabolite coefficient of variation of 20 percent or lower in quality control injections revealed that probabilistic quotient normalisation yielded 320 compliant metabolites, slightly surpassing non-normalized data at 308 metabolites. In contrast, creatinine normalisation substantially degraded data precision, leaving only 138 metabolites meeting the threshold. Detailed analytical tracking confirmed that analytical measurement of creatinine was highly stable, showing a coefficient of variation of only 3.0 percent in pooled quality control samples and consistent behavior from a 15N2-labelled tryptophan internal standard, which showed analytical variability of 14.4 percent across runs. Across patient spot-urine samples, however, creatinine biological excretion varied by approximately 29 to 35 percent, spanning a ten-fold concentration range between extreme samples. Normalizing against this single biologically fluctuating molecule propagated physiological variance across all measured features, demonstrating that probabilistic quotient normalisation represents the far more reliable post-acquisition correction method for clinical urine metabolomics.

Subject of Research: Optimisation of high-throughput urinary metabolomics via dilute-and-shoot UHPLC-MS

Article Title: Optimisation of a dilute-and-shoot UHPLC-MS method for high-throughput urinary metabolomics

Article References: Kelly, P., Kerbiriou, C., White, B., Gkikas, K., Stewart, K., Farrell, G., Gerasimidis, K., & Rattray, N. J. W. (2026). Optimisation of a dilute-and-shoot UHPLC-MS method for high-throughput urinary metabolomics. Metabolomics, 22(6), Article 176. https://doi.org/10.1007/s11306-026-02542-1

Image Credits: AI Generated

DOI: 10.1007/s11306-026-02542-1

Keywords: urinary metabolomics, dilute-and-shoot, UHPLC-MS, liquid chromatography, mass spectrometry, high-throughput screening, inflammatory bowel disease, metabolite extraction, creatinine normalisation, probabilistic quotient normalisation, peak quality factors, orbitrap, biomarker discovery, clinical metabolomics, chromatography gradient, automatic gain control

News Source: Alexandra Wallace. (November 13, 2026). Optimised Ten-Minute Urine Test Speeds High-Throughput Clinical Metabolomics Screening. Scienmag.

Tags: automatic gain controlbiomarker discoverychromatography gradientclinical metabolomicscreatinine normalisationdilute-and-shoothigh-throughput screeninginflammatory bowel diseaseliquid chromatographymass spectrometrymetabolite extractionOrbitrappeak quality factorsprobabilistic quotient normalisationUHPLC-MSurinary metabolomics
Share12Tweet7Share2ShareShareShare1

Related Posts

Bacteriophages Suppress Resistant Pseudomonas aeruginosa Isolates in Laboratory Assessment

Bacteriophages Suppress Resistant Pseudomonas aeruginosa Isolates in Laboratory Assessment

November 17, 2026
Yarrowia lipolytica Yeast Mobilizes Phosphate and Enhances Tomato and Maize Growth

Yarrowia lipolytica Yeast Mobilizes Phosphate and Enhances Tomato and Maize Growth

November 17, 2026

Green Prickly Ash Cultivars Show Distinct Volatile Profiles Across Two Harvest Years

November 17, 2026

Neonatal Stem Cell Therapies Face Critical Efficacy and Translation Bottlenecks

November 17, 2026

POPULAR NEWS

  • Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

    Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

    29 shares
    Share 12 Tweet 7
  • Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

    29 shares
    Share 12 Tweet 7
  • Cerebral Autoregulation Index Fluctuates Widely During One-Lung Ventilation in Two Cases

    29 shares
    Share 12 Tweet 7
  • Bacteriophages Suppress Resistant Pseudomonas aeruginosa Isolates in Laboratory Assessment

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

Cerebral Autoregulation Index Fluctuates Widely During One-Lung Ventilation in Two Cases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.